Walking Exercise for Mild Cognitive Impairment
(EXEC Trial)
Trial Summary
The trial information does not specify whether you need to stop taking your current medications. However, if you have a major psychiatric disorder or unstable clinical depression, medication adjustments within 3 months of enrollment may affect eligibility.
Research shows that exercise can significantly improve cognitive function in people with mild cognitive impairment. Studies have found that various forms of exercise, including walking, can enhance cognitive abilities and physical function, making it a promising treatment option.
12345Research shows that home-based exercise programs, including walking, are generally safe for people with mild cognitive impairment. Studies found no major adverse events, and participants were able to complete the exercises successfully.
46789Home-based walking exercise is unique because it is a low-cost, low-technology treatment that can be done at home, making it accessible and easy to incorporate into daily life. Unlike other treatments that may require special equipment or settings, walking is simple and has been shown to improve cognition and mobility in older adults.
48101112Eligibility Criteria
This trial is for English-speaking adults aged 55 or older with stage 3-4 chronic kidney disease and mild cognitive impairment, but no major head trauma, dementia, severe physical limitations, uncontrolled heart conditions, high blood pressure, or psychiatric disorders requiring medical therapy. Participants must be able to undergo an MRI and not be in a supervised exercise program.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants undergo tests for heart health, physical function, memory testing, and brain structure and function using imaging
Treatment
Participants are randomized to a 6-month home-based walking program or health education, with ongoing telephone coaching and use of a Fitbit fitness tracker
Follow-up
Participants are monitored for changes in cognitive function, brain structure, and other health metrics